Titlebook: Antiemetics in the Supportive Care of Cancer Patients; Maurizio Tonato Conference proceedings 1996 Springer-Verlag Berlin Heidelberg 1996

legerdemain

书目名称Antiemetics in the Supportive Care of Cancer Patients影响因子(影响力)




书目名称Antiemetics in the Supportive Care of Cancer Patients影响因子(影响力)学科排名




书目名称Antiemetics in the Supportive Care of Cancer Patients网络公开度




书目名称Antiemetics in the Supportive Care of Cancer Patients网络公开度学科排名




书目名称Antiemetics in the Supportive Care of Cancer Patients被引频次




书目名称Antiemetics in the Supportive Care of Cancer Patients被引频次学科排名




书目名称Antiemetics in the Supportive Care of Cancer Patients年度引用




书目名称Antiemetics in the Supportive Care of Cancer Patients年度引用学科排名




书目名称Antiemetics in the Supportive Care of Cancer Patients读者反馈




书目名称Antiemetics in the Supportive Care of Cancer Patients读者反馈学科排名

single

有害

连锁

The Mechanism of Emesis Induced by Chemotherapy and Radiotherapy,oth have a variety of deleterious effects on the patient’s quality of life during treatment. Vomiting itself places a considerable physical stress on the body in patients who may already be weakened by their disease and any concomitant surgery. Tearing of the oesophagus (Mallory-Weiss Syndrome) and

形上升才刺激

fetter

Methodology of Antiemetic Trials,and tolerability of therapies in cancer patients receiving chemotherapy. This is necessary not only to obtain optimal control of systematic errors, but also to describe their influence on the statistical analysis of the responses.

施舍

Prevention of Acute Cisplatin-Induced Nausea and Vomiting,derlines the differences in mechanisms responsible for the difference in onset and duration of this side-effect. Cisplatin is one of the most widely used cytotoxic agents and has significantly contributed to the curative potential of chemotherapy. However, the spectrum of side-effects is substantial

ARCHE

Prevention of Acute Emesis from Other Emetogenic Drugs,shows a ranking of the emetic potential of several antitumour agents different from cisplatin. It is important to point out that the final intensity of emesis is not only related to the intrinsic emetic capacity of the antitumour drug, but to other prognostic factors such as gender of the patient, p

calamity

Therapeutic Approach to Delayed Emesis,raph. At present, in adults submitted to highly emetogenic chemotherapy, nausea and vomiting should be a rare event in the first 24 hours of observation, with only 5% or less of the patients failing antiemetic therapy completely (more than 5 episodes of emesis), and over 60% fully protected from bot

Atmosphere